Signs and symptoms linked with withdrawal are relatively consistent in pediatric population; can be seen after five or more days of opioids ...

Cassandra Pingali, MPH, from the CDC in Atlanta, and colleagues analyzed data from the 2024 National Immunization Survey-Teen to examine national, state, and selected local area vaccination coverage ...

HealthDay News — Patients with advanced desmoplastic melanoma have high response to single-agent anti-programmed death protein 1 (PD-1) therapy, according to a study published online August 14 in ...

The new AAP schedule provides guidance for routine immunization against 18 diseases, including updates for RSV, influenza, and COVID-19 immunization.

ADX-2191 is a preservative-free intravitreal formulation of methotrexate designed to treat various rare retinal diseases such as retinitis pigmentosa.

The original NDA submission included data from the registration-directed phase 3 MOVE-FA trial as well as 2 long-term studies evaluating vatiquinone in FA.

The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.